hAd5-S-Fusion+N-ETSD vaccine

BIOLOGICAL4 trials

Sponsors

ImmunityBio, Inc.

Conditions

COVID-19Covid19

Phase 1

COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers

CompletedNCT04591717

ImmunityBio, Inc.COVID-19

Start: 2020-10-19End: 2023-01-18Updated: 2023-02-28

COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults

CompletedNCT04710303

ImmunityBio, Inc.Covid19

Start: 2021-03-02End: 2022-08-02Updated: 2024-11-15

COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines

WithdrawnNCT04843722

ImmunityBio, Inc.Covid19

Start: 2021-12-31End: 2021-12-14Updated: 2025-02-21

COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines

WithdrawnNCT04845191

ImmunityBio, Inc.Covid19

Start: 2021-12-31End: 2021-12-14Updated: 2025-02-21